Back
Corvus Pharmaceuticals Stock Predictions
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Sell
49
CRVS
Corvus Pharmaceuticals
Last Price:
$3.63
Seasonality Move:
14.14%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Corvus Pharmaceuticals Stock Forecast
-
Is Corvus Pharmaceuticals Stock Undervalued?The current Corvus Pharmaceuticals [CRVS] share price is $3.89. The Score for CRVS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
CRVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Corvus Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Corvus Pharmaceuticals Stock Rating
Data Unavailable
Corvus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
corvuspharma.com
52-Week Data
52-Week High:
10.00
52-Week Low:
1.75
Prediction Charts
Market Cap:
300M
Price in USD:
3.89
Volume:
855.5K
Beta:
1.20
Technical Analysis
SMA50:
3.67
SMA100:
4.42
SMA200:
5.23
52-Wk Change:
84.36%
Stock Predictions
-
Is Corvus Pharmaceuticals stock public?Yes, Corvus Pharmaceuticals is a publicly traded company.
-
What is the Corvus Pharmaceuticals stock quote today?The Corvus Pharmaceuticals stock price is 3.89 USD today.
-
How to buy Corvus Pharmaceuticals stock online?You can buy Corvus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-24 | 3.55 | 3.66 | 3.78 | 3.53 |
| Apr-25 | 3.68 | 3.63 | 3.73 | 3.61 |
| Apr-28 | 3.70 | 3.50 | 3.76 | 3.48 |
| Apr-29 | 3.50 | 3.62 | 3.69 | 3.41 |
| Apr-30 | 3.57 | 3.59 | 3.67 | 3.51 |
| May-1 | 3.58 | 3.52 | 3.58 | 3.47 |
| May-2 | 3.67 | 3.62 | 3.71 | 3.59 |
| May-5 | 3.58 | 3.57 | 3.66 | 3.52 |
| May-6 | 3.56 | 3.35 | 3.56 | 3.33 |
| May-7 | 3.38 | 3.20 | 3.38 | 3.17 |
| May-8 | 3.19 | 3.35 | 3.49 | 3.17 |
| May-9 | 4.22 | 4.43 | 4.49 | 3.93 |
| May-12 | 4.42 | 4.06 | 4.53 | 3.84 |
| May-13 | 4.07 | 3.89 | 4.11 | 3.88 |
Corvus Pharmaceuticals Earnings
Data Unavailable
Corvus Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.37 per share.
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.